NovaGo Therapeutics AG develops therapies targeting Nogo-A to enhance nerve-fiber growth, aiming to improve recovery after spinal cord injuries. Their work focuses on restoring sensation and functional outcomes for patients.
Founded
2015
Total Funding
$10M+
Total Rounds
2
First Raise
Mar 4, 2019
Latest Raise
Sep 2, 2026
New funding rounds in your inbox every week 路 No noise, all Signal.
Founders and leadership hierarchy for this company.
| Date | Deal Type | Amount | Lead Investor |
|---|---|---|---|
| 9/2/2026 | |||
1 more funding round available
Upgrade to Premium to view all historical funding rounds
Upgrade to Premium to view Capital Momentum Score and performance metrics
New funding rounds in your inbox every week 路 Free